vs
Astrana Health, Inc.（ASTH）与Evercore Inc.（EVR）财务数据对比。点击上方公司名可切换其他公司
Evercore Inc.的季度营收约是Astrana Health, Inc.的1.4倍（$1.3B vs $950.5M），Evercore Inc.净利率更高（15.7% vs 0.7%，领先15.0%），Astrana Health, Inc.同比增速更快（42.9% vs 32.4%），Evercore Inc.自由现金流更多（$798.6M vs $-6.0M），过去两年Astrana Health, Inc.的营收复合增速更高（53.3% vs 48.9%）
Astrana Health是一家总部位于美国的价值导向型医疗服务提供商，主要服务全美符合联邦医保资格的老年群体，提供上门初级护理、慢性病管理及护理协调服务，致力于提升患者健康水平、降低不必要的医疗支出。
Evercore Inc.（前称Evercore Partners）是1995年由罗杰·奥尔特曼、大卫·奥芬森德、奥斯汀·博伊特纳联合创立的全球独立投资银行咨询机构。成立至今，公司已为总规模超4.7万亿美元的并购、重组交易提供专业咨询服务，在全球投行业务领域拥有较高声誉。
ASTH vs EVR — 直观对比
营收规模更大
EVR
是对方的1.4倍
$950.5M
营收增速更快
ASTH
高出10.5%
32.4%
净利率更高
EVR
高出15.0%
0.7%
自由现金流更多
EVR
多$804.6M
$-6.0M
两年增速更快
ASTH
近两年复合增速
48.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $950.5M | $1.3B |
| 净利润 | $6.6M | $204.0M |
| 毛利率 | — | — |
| 营业利润率 | 1.9% | 24.2% |
| 净利率 | 0.7% | 15.7% |
| 营收同比 | 42.9% | 32.4% |
| 净利润同比 | 184.4% | 45.2% |
| 每股收益（稀释后） | $0.12 | $4.80 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASTHEVR
| Q4 25 | $950.5M | $1.3B | ||
| Q3 25 | $956.0M | $1.0B | ||
| Q2 25 | $654.8M | $838.0M | ||
| Q1 25 | $620.4M | $699.0M | ||
| Q4 24 | $665.2M | $979.5M | ||
| Q3 24 | $478.7M | $738.4M | ||
| Q2 24 | $486.3M | $693.4M | ||
| Q1 24 | $404.4M | $585.0M |
净利润ASTHEVR
| Q4 25 | $6.6M | $204.0M | ||
| Q3 25 | $373.0K | $144.6M | ||
| Q2 25 | $9.4M | $97.2M | ||
| Q1 25 | $6.7M | $146.2M | ||
| Q4 24 | $-7.8M | $140.4M | ||
| Q3 24 | $16.1M | $78.4M | ||
| Q2 24 | $19.2M | $73.8M | ||
| Q1 24 | $14.8M | $85.7M |
营业利润率ASTHEVR
| Q4 25 | 1.9% | 24.2% | ||
| Q3 25 | 2.0% | 20.8% | ||
| Q2 25 | 3.1% | 18.0% | ||
| Q1 25 | 3.3% | 16.0% | ||
| Q4 24 | 0.1% | 21.8% | ||
| Q3 24 | 5.9% | 16.7% | ||
| Q2 24 | 6.2% | 15.9% | ||
| Q1 24 | 7.5% | 14.8% |
净利率ASTHEVR
| Q4 25 | 0.7% | 15.7% | ||
| Q3 25 | 0.0% | 13.8% | ||
| Q2 25 | 1.4% | 11.6% | ||
| Q1 25 | 1.1% | 20.9% | ||
| Q4 24 | -1.2% | 14.3% | ||
| Q3 24 | 3.4% | 10.6% | ||
| Q2 24 | 3.9% | 10.6% | ||
| Q1 24 | 3.7% | 14.6% |
每股收益（稀释后）ASTHEVR
| Q4 25 | $0.12 | $4.80 | ||
| Q3 25 | $0.01 | $3.41 | ||
| Q2 25 | $0.19 | $2.36 | ||
| Q1 25 | $0.14 | $3.48 | ||
| Q4 24 | $-0.14 | $3.32 | ||
| Q3 24 | $0.33 | $1.86 | ||
| Q2 24 | $0.40 | $1.81 | ||
| Q1 24 | $0.31 | $2.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $429.5M | $3.0B |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $779.3M | $2.0B |
| 总资产 | $2.2B | $5.4B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASTHEVR
| Q4 25 | $429.5M | $3.0B | ||
| Q3 25 | $463.4M | $2.4B | ||
| Q2 25 | $342.1M | $1.7B | ||
| Q1 25 | $260.9M | $1.4B | ||
| Q4 24 | $290.8M | $2.4B | ||
| Q3 24 | $350.3M | $1.8B | ||
| Q2 24 | $327.7M | $1.7B | ||
| Q1 24 | $337.3M | $1.4B |
股东权益ASTHEVR
| Q4 25 | $779.3M | $2.0B | ||
| Q3 25 | $775.5M | $1.8B | ||
| Q2 25 | $765.5M | $1.7B | ||
| Q1 25 | $745.4M | $1.5B | ||
| Q4 24 | $712.7M | $1.7B | ||
| Q3 24 | $704.6M | $1.6B | ||
| Q2 24 | $678.9M | $1.5B | ||
| Q1 24 | $653.5M | $1.4B |
总资产ASTHEVR
| Q4 25 | $2.2B | $5.4B | ||
| Q3 25 | $2.2B | $4.4B | ||
| Q2 25 | $1.4B | $3.7B | ||
| Q1 25 | $1.3B | $3.3B | ||
| Q4 24 | $1.4B | $4.2B | ||
| Q3 24 | $1.3B | $3.6B | ||
| Q2 24 | $1.3B | $3.3B | ||
| Q1 24 | $1.2B | $3.0B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.9M | $807.5M |
| 自由现金流经营现金流 - 资本支出 | $-6.0M | $798.6M |
| 自由现金流率自由现金流/营收 | -0.6% | 61.6% |
| 资本支出强度资本支出/营收 | 0.3% | 0.7% |
| 现金转化率经营现金流/净利润 | -0.44× | 3.96× |
| 过去12个月自由现金流最近4个季度 | $104.5M | $1.2B |
8季度趋势，按日历期对齐
经营现金流ASTHEVR
| Q4 25 | $-2.9M | $807.5M | ||
| Q3 25 | $10.0M | $560.9M | ||
| Q2 25 | $90.9M | $437.7M | ||
| Q1 25 | $16.6M | $-549.7M | ||
| Q4 24 | $-10.9M | $686.4M | ||
| Q3 24 | $34.0M | $234.5M | ||
| Q2 24 | $23.2M | $348.5M | ||
| Q1 24 | $6.0M | $-281.2M |
自由现金流ASTHEVR
| Q4 25 | $-6.0M | $798.6M | ||
| Q3 25 | $7.4M | $541.5M | ||
| Q2 25 | $89.5M | $411.7M | ||
| Q1 25 | $13.6M | $-569.3M | ||
| Q4 24 | $-13.5M | $673.1M | ||
| Q3 24 | $31.7M | $226.6M | ||
| Q2 24 | $20.4M | $340.7M | ||
| Q1 24 | $5.6M | $-282.3M |
自由现金流率ASTHEVR
| Q4 25 | -0.6% | 61.6% | ||
| Q3 25 | 0.8% | 51.8% | ||
| Q2 25 | 13.7% | 49.1% | ||
| Q1 25 | 2.2% | -81.4% | ||
| Q4 24 | -2.0% | 68.7% | ||
| Q3 24 | 6.6% | 30.7% | ||
| Q2 24 | 4.2% | 49.1% | ||
| Q1 24 | 1.4% | -48.3% |
资本支出强度ASTHEVR
| Q4 25 | 0.3% | 0.7% | ||
| Q3 25 | 0.3% | 1.9% | ||
| Q2 25 | 0.2% | 3.1% | ||
| Q1 25 | 0.5% | 2.8% | ||
| Q4 24 | 0.4% | 1.4% | ||
| Q3 24 | 0.5% | 1.1% | ||
| Q2 24 | 0.6% | 1.1% | ||
| Q1 24 | 0.1% | 0.2% |
现金转化率ASTHEVR
| Q4 25 | -0.44× | 3.96× | ||
| Q3 25 | 26.69× | 3.88× | ||
| Q2 25 | 9.65× | 4.50× | ||
| Q1 25 | 2.48× | -3.76× | ||
| Q4 24 | — | 4.89× | ||
| Q3 24 | 2.11× | 2.99× | ||
| Q2 24 | 1.21× | 4.72× | ||
| Q1 24 | 0.40× | -3.28× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
EVR
| Advisory Fees | $1.1B | 87% |
| Commissions And Related Revenue | $66.5M | 5% |
| Underwriting Fees | $49.5M | 4% |
| Other | $29.6M | 2% |
| Investment Management | $23.2M | 2% |
